Ohio Bextra® Lawyers
BEXTRA® CLAIMS
Schedule a consultation or ask us a free legal question
What is Bextra®?
It is a prescription pain medicine. It falls into a broad category known as nonsteroidal anti-inflammatory drugs, and it is in a category called Cox-2 inhibitors.
When did it go off the market?
April 7, 2005, in the United States and Europe, followed by worldwide withdrawal.
Who is the manufacturer?
Pfizer, which has its headquarters in New York.
Why was it taken off the market?
Its risk of causing heart attacks, strokes, and Stevens Johnson Syndrome outweighs its usefulness as a pain reliever.
What problems can it cause?
It increases the risk of heart attack, stroke, pulmonary embolism, and Stevens Johnson Syndrome, all of which can be fatal.
What is Stevens Johnson Syndrome?
Stevens Johnson Syndrome, also called toxic epidermal necrolysis, is a severe allergic reaction to a drug. It usually begins with fever, cough, and other nonspecific symptoms, and is soon followed by purplish, bloody-looking lesions on the skin and mucous membranes. These early lesions, typically found on the head, neck, and upper chest, soon merge and blister. Sheets of epidermis then begin to detach from the skin layers below. In time, the entire surface of the skin may be involved, with detachment of 100% of the epidermis.
Do I have a case?
Anyone who had a heart attack, stroke, Stevens Johnson Syndrome, or pulmonary embolism while taking Bextra® has a potential case.
If you or someone you know has suffered serious side effects from the use of Bextra®, call or e-mail the experienced Ohio Bextra® attorneys at Clark, Perdue & List today.
